Recruiting

Nasal SprayOcular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

Sponsor:

UCLA

Code:

NCT07606625

Conditions

Dry Eye

Meibomian Gland Dysfunction

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Varenicline 0.03Mg/Spray Nasal Soln

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-29. This information was provided to ClinicalTrials.gov by University of California, Berkeley on 2026-05-27.